Harnessing Biomarker Testing for Evidence-Based Treatment Decision-Making in Advanced G/GEJ Cancers

Harnessing Biomarker Testing for Evidence-Based Treatment Decision-Making in Advanced G/GEJ Cancers

Unlock expert strategies to enhance biomarker testing and streamline evidence-based treatment decision-making in advanced G/GEJ cancers! In this on-demand video, a leading oncologist along with an expert pathologist will discuss practical tips to overcome common barriers in the community oncology setting, dive into the latest clinical data, and share tools to foster collaboration between oncology and pathology teams, including multidisciplinary tumor boards. Plus, download a valuable biomarker testing tool to support your clinical practice. Join us to elevate your practice and improve outcomes with biomarker-driven, targeted therapies!

  • Provider:PRIME Education, Inc. (PRIME®)
  • Activity Link: https://primeinc.org/online/applying-precision-oncology-advanced-g-gej-optimizing-integration-biomarker
  • Start Date: 2024-12-05 06:00:00
  • End Date: 2024-12-05 06:00:00
  • Credit Details: IPCE Credits: 0.5 hours
    AAPA Category 1 Credit™️: 0.5 hours
    AMA PRA Category 1 Credit™️: 0.5 hours
    Nursing: 0.5 hours
    Pharmacy: 0.5 hours
  • Commercial Support: Source: Merck (Any division) - Amount: 51666.67 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.